Citadel Advisors LLC

SEC CIK: 0001423053
Latest filing: Sep 1, 2026

SEC filings (opens in a new tab)

MDNAF holding history

Medicenna Therapeutics Corp. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MDNAF overview All 13F holders of MDNAF Full Q2 2026 holdings

Shares (Q4 2023): 0; Sold out in Q4 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2021

Holdings of MDNAF by Citadel Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2023	0	$0	0.0%	−27,626−100.0%	Sold out	Holders
Q3 2023	27,626	$7.90K	<0.1%	+27,626	New	Holders
Q3 2021	0	$0	0.0%	−24,203−100.0%	Sold out	Holders
Q2 2021	24,203	$73.0K	<0.1%	+24,203	New	Holders